SOLS Nuclear Investor Highlights Significant Growth; Raising Target to $101

Research evidence excerpt

SOLS Nuclear Investor Highlights Significant Growth; Raising Target to $101

purport to meet the objectives or needs of specific recipients. Nothing herein constitutes any investment, legal, tax or other advice nor is it to be

relied on in any investment or decision. If you are in doubt about any of the contents of this document, the reader should obtain independent

professional advice. This material is for information purposes only and is not an offer to sell or the solicitation of an offer to buy any security.

In furnishing this report, BMO Capital Markets intends to take advantage of the exemption from the principal and agency trading restrictions

in Section 206(3) of the Investment Advisers Act of 1940 and Rule 206(3)-1 thereunder. Accordingly, recipients of this report are advised that

BMO Capital Markets or its affiliates may act as principal for its own account or agent for another person in connection with the purchase or sale

of any security mentioned in or the subject of this report. BMO Capital Markets or its affiliates, officers, directors or employees have a long or

short position in many of the securities discussed herein, related securities or in options, futures or other derivative instruments based thereon.

The reader should assume that BMO Capital Markets or its affiliates may have a conflict of interest and should not rely solely on this report in

evaluating whether or not to buy or sell securities of issuers discussed herein.

Additional Matters

This report is directed only at entities or persons in jurisdictions or countries where access to and use of the information is not contrary to local

laws or regulations. Its contents have not been reviewed by any regulatory authority. BMO Capital Markets does not represent that this report